Overview
Transposition of the great arteries (TGA), also known as dextro-transposition of the great arteries (d-TGA), is a serious congenital heart defect in which the two main arteries leaving the heart are switched (transposed). The aorta, which normally carries oxygen-rich blood from the left ventricle to the body, instead arises from the right ventricle and carries oxygen-poor blood. The pulmonary artery, which normally carries oxygen-poor blood from the right ventricle to the lungs, instead arises from the left ventricle. This creates two parallel circuits rather than the normal series circulation, meaning oxygen-poor blood is recirculated through the body without passing through the lungs for oxygenation, while oxygen-rich blood recirculates through the lungs without being delivered to the body. Newborns with TGA typically present with severe cyanosis (bluish discoloration of the skin) shortly after birth, along with rapid breathing, poor feeding, and respiratory distress. Survival depends on the presence of some communication between the two circuits, such as a patent foramen ovale, atrial septal defect, ventricular septal defect, or patent ductus arteriosus, which allows some mixing of oxygenated and deoxygenated blood. Without intervention, TGA is fatal in the neonatal period. Immediate management often includes prostaglandin E1 infusion to maintain the patent ductus arteriosus and a balloon atrial septostomy (Rashkind procedure) to improve mixing of blood at the atrial level. The definitive treatment is the arterial switch operation (Jatene procedure), which is typically performed within the first two weeks of life and involves reconnecting the great arteries to their correct ventricles along with reimplantation of the coronary arteries. Long-term outcomes following the arterial switch operation are generally excellent, though lifelong cardiac follow-up is required to monitor for potential complications such as coronary artery stenosis, neoaortic valve regurgitation, or pulmonary artery stenosis. The etiology of TGA is considered multifactorial, with both genetic and environmental factors contributing, though the exact cause remains incompletely understood in most cases.
Multifactorial
Caused by a mix of several genes and environmental factors
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Transposition of the great arteries.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Transposition of the great arteries at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Transposition of the great arteries.
Community
No community posts yet. Be the first to share your experience with Transposition of the great arteries.
Start the conversation →Latest news about Transposition of the great arteries
Disease timeline:
New recruiting trial: Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)
A new clinical trial is recruiting patients for Transposition of the great arteries
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Transposition of the great arteries
What is Transposition of the great arteries?
Transposition of the great arteries (TGA), also known as dextro-transposition of the great arteries (d-TGA), is a serious congenital heart defect in which the two main arteries leaving the heart are switched (transposed). The aorta, which normally carries oxygen-rich blood from the left ventricle to the body, instead arises from the right ventricle and carries oxygen-poor blood. The pulmonary artery, which normally carries oxygen-poor blood from the right ventricle to the lungs, instead arises from the left ventricle. This creates two parallel circuits rather than the normal series circulation
How is Transposition of the great arteries inherited?
Transposition of the great arteries follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Transposition of the great arteries typically begin?
Typical onset of Transposition of the great arteries is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Transposition of the great arteries?
25 specialists and care centers treating Transposition of the great arteries are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.